ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data…
Comprehensive new edition highlights growth opportunities and evolving regulation across six Latin American securities finance markets. NEW YORK, Oct. 15,…
Transparency Notification from Shareholder Ghent, Belgium – 13 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or…
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund…
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025. Sanofi announced today that its Q3 2025…
Next-gen security meets mobile freedom. SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ -- Freedom Factory starts shipping its groundbreaking mobile device,…
MUMBAI, India, Sept. 22, 2025 /PRNewswire/ -- Standard Chartered Bank, in collaboration with Dun & Bradstreet, a global leader in business decisioning…
PRESS RELEASE - 09/15/2025, 09:00 AM EDT Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test First-ever fully automated,…
BMNR investor presentation walks you through "the Alchemy of 5%" BitMine Crypto + Cash Holdings of $8.98 billion, including 1.87…
RICHARDSON, Texas, Aug. 20, 2025 /PRNewswire/ -- Global superstar, actor, and philanthropist Nick Jonas has teamed up with leading watch…